Scynexis Inc. (SCYX) NASDAQ
$1.45 0.05 (3.20%)
Market Cap: $53.04M
As of 04/19/24 02:44 PM EDT. Market open.
Scynexis Inc. (SCYX)
NASDAQ
$1.45
0.05 (3.20%)
Market Cap: $53.04M
As of 04/19/24 02:44 PM EDT. Market open.
Add to Portfolio
scynexis, inc. is a pharmaceutical company committed to the discovery, development and commercialization of novel anti-infectives to address significant unmet therapeutic needs. our scientists have extensive experience in the life sciences industry having, together and individually, been involved in the discovery and development of innovative medicines over a broad range of therapy areas. we ... read more
scynexis, inc. is a pharmaceutical company committed to the discovery, development and commercialization of novel anti-infectives to address significant unmet therapeutic needs. our scientists have extensive experience in the life sciences industry having, together and individually, been involved in the discovery and development of innovative medicines over a broad range of therapy areas. we are developing our lead product candidate, scy-078, a novel antifungal in phase 2, as a novel oral and intravenous drug for the treatment of serious and life-threatening invasive fungal infections in humans. read less
COMPANY PROFILE
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
Full Time Employees
81
URL
Address
1 Evertrust Plz Fl 13, New Jersey, Jersey City, 07302-3051.
PRICE CHART FOR SCYNEXIS INC
From:
To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$1.41
Previous Close
$1.41
Days Range
$1.40 - $1.47
52 week range
$1.35 - $3.87
Volume
103,964
Avg. Volume (30 days)
204,019
Market Cap
$53.04M
Dividend Yield
-
P/E
0.79
Shares Outstanding
37,753,481
Open
$1.41
Previous Close
$1.41
Days Range
$1.40 - $1.47
52 week range
$1.35 - $3.87
Volume
103,964
Avg. Volume (30 days)
204,019
Market Cap
$53.04M
Dividend Yield
-
P/E
0.79
Shares Outstanding
37,753,481
FINANCIAL STATEMENTS FOR SCYNEXIS INC
LOADING...
Open in: 
Open in:
INSIDER TRANSACTIONS FOR SCYNEXIS INC
| Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
| Sukenick Scott | Chief Legal Officer | Feb 16, 2024 | Option Exercise | $1.63 | 15,179 | 24,742 | 336,195 | Feb 16, 2024, 05:48 PM |
| Taglietti Marco | Chief Executive Officer | Apr 26, 2022 | Buy | $3.00 | 75,000 | 225,000 | 272,068 | Apr 28, 2022, 07:25 AM |
| Sukenick Scott | General Counsel | Apr 26, 2022 | Buy | $3.00 | 3,500 | 10,500 | 53,499 | Apr 28, 2022, 07:24 AM |
| PERCEPTIVE ADVISORS LLC | 10% Owner | Jan 21, 2021 | Sale | $7.38 | 95,000 | 701,100 | 2,120,000 | Jan 26, 2021, 09:57 PM |
| PERCEPTIVE ADVISORS LLC | 10% Owner | Jan 20, 2021 | Sale | $7.43 | 185,000 | 1,374,550 | 2,215,000 | Jan 26, 2021, 09:57 PM |
| PERCEPTIVE ADVISORS LLC | 10% Owner | Jan 22, 2021 | Sale | $8.24 | 319,000 | 2,629,781 | 1,833,849 | Jan 26, 2021, 09:57 PM |
| Tinmouth Brian Philippe | Director | Dec 21, 2020 | Buy | $6.25 | 8,000 | 50,000 | 8,000 | Dec 23, 2020, 09:12 AM |
| Taglietti Marco | Chief Executive Officer | Dec 21, 2020 | Buy | $6.25 | 40,000 | 250,000 | 109,668 | Dec 23, 2020, 09:10 AM |
| Sukenick Scott | General Counsel | Dec 21, 2020 | Buy | $6.25 | 1,600 | 10,000 | 9,099 | Dec 23, 2020, 09:10 AM |
| Macdonald Guy | Director | Dec 21, 2020 | Buy | $6.25 | 8,000 | 50,000 | 12,000 | Dec 23, 2020, 09:09 AM |
| HANHAM ANN | Director | Dec 21, 2020 | Buy | $6.25 | 3,200 | 20,000 | 3,622 | Dec 23, 2020, 09:07 AM |
| GILMAN STEVEN C | Director | Dec 21, 2020 | Buy | $6.25 | 4,000 | 25,000 | 4,000 | Dec 23, 2020, 09:06 AM |
| Francois Eric | Chief Financial Officer | Dec 21, 2020 | Buy | $6.25 | 600 | 3,750 | 11,732 | Dec 23, 2020, 09:05 AM |
| ANIDO ARMANDO | Director | Dec 21, 2020 | Buy | $6.25 | 5,000 | 31,250 | 5,000 | Dec 23, 2020, 09:02 AM |
| Angulo Gonzalez David | Chief Medical Officer | Dec 21, 2020 | Buy | $6.25 | 1,600 | 10,000 | 23,780 | Dec 23, 2020, 09:00 AM |
| Sukenick Scott | General Counsel | Nov 25, 2020 | Option Exercise | $6.81 | 2,613 | 17,795 | 7,499 | Dec 04, 2020, 09:00 PM |
| Sukenick Scott | General Counsel | Feb 15, 2020 | Option Exercise | $9.80 | 783 | 7,673 | 9,912 | Dec 04, 2020, 09:00 PM |
| Francois Eric | Chief Financial Officer | Nov 25, 2020 | Option Exercise | $6.81 | 3,480 | 23,699 | 11,132 | Dec 04, 2020, 08:59 PM |
| Francois Eric | Chief Financial Officer | Feb 15, 2020 | Option Exercise | $9.80 | 979 | 9,594 | 14,412 | Dec 04, 2020, 08:59 PM |
| Angulo Gonzalez David | Chief Medical Officer | Nov 25, 2020 | Option Exercise | $6.81 | 4,323 | 29,440 | 22,180 | Dec 04, 2020, 08:57 PM |
| Angulo Gonzalez David | Chief Medical Officer | Feb 15, 2020 | Option Exercise | $9.80 | 1,175 | 11,515 | 26,303 | Dec 04, 2020, 08:57 PM |
| Taglietti Marco | Chief Executive Officer | Dec 12, 2019 | Buy | $0.90 | 166,667 | 150,000 | 693,682 | Dec 16, 2019, 03:10 PM |
| Taglietti Marco | Chief Executive Officer | Aug 21, 2019 | Buy | $1.11 | 9,500 | 10,545 | 526,015 | Aug 22, 2019, 08:22 AM |
| Taglietti Marco | Chief Executive Officer | Aug 20, 2019 | Buy | $1.11 | 500 | 555 | 516,515 | Aug 22, 2019, 08:22 AM |
| Taglietti Marco | Chief Executive Officer | Aug 15, 2019 | Buy | $1.01 | 10,015 | 10,115 | 516,015 | Aug 19, 2019, 08:31 AM |
| Taglietti Marco | Chief Executive Officer | Apr 17, 2019 | Buy | $1.63 | 25,000 | 40,750 | 506,000 | Apr 18, 2019, 08:39 AM |
| Taglietti Marco | Chief Executive Officer | Jan 10, 2019 | Buy | $0.69 | 25,000 | 17,250 | 480,000 | Jan 14, 2019, 09:04 AM |
| Taglietti Marco | Chief Executive Officer | Dec 31, 2018 | Buy | $0.46 | 25,000 | 11,500 | 455,000 | Jan 02, 2019, 11:28 AM |
| Angulo Gonzalez David | Chief Medical Officer | Dec 31, 2018 | Buy | $0.50 | 12,000 | 5,951 | 121,790 | Jan 02, 2019, 11:28 AM |
| Angulo Gonzalez David | Chief Medical Officer | Sep 06, 2018 | Buy | $1.27 | 7,000 | 8,890 | 108,790 | Sep 10, 2018, 09:09 AM |
| Taglietti Marco | Chief Executive Officer | Aug 23, 2018 | Buy | $1.29 | 25,000 | 32,250 | 429,000 | Aug 27, 2018, 08:29 AM |
| Angulo Gonzalez David | Chief Medical Officer | Mar 29, 2018 | Buy | $1.36 | 6,000 | 8,160 | 101,790 | Apr 02, 2018, 08:10 AM |
| Angulo Gonzalez David | Chief Medical Officer | Mar 08, 2018 | Buy | $1.39 | 7,000 | 9,730 | 95,790 | Mar 12, 2018, 04:43 PM |
| HASTINGS DAVID C | Director | Mar 08, 2018 | Buy | $1.69 | 11,834 | 19,999 | 31,834 | Mar 12, 2018, 08:52 AM |
| Sukenick Scott | General Counsel | Mar 08, 2018 | Buy | $1.69 | 2,959 | 5,001 | 2,959 | Mar 12, 2018, 08:51 AM |
| Taglietti Marco | Chief Executive Officer | Mar 08, 2018 | Buy | $1.69 | 100,000 | 169,000 | 404,000 | Mar 12, 2018, 08:50 AM |
| Francois Eric | Chief Financial Officer | Mar 08, 2018 | Buy | $1.69 | 5,917 | 10,000 | 24,917 | Mar 12, 2018, 08:49 AM |
| Angulo Gonzalez David | Chief Medical Officer | Mar 08, 2018 | Buy | $1.69 | 14,790 | 24,995 | 88,790 | Mar 12, 2018, 08:48 AM |
| Taglietti Marco | Chief Executive Officer | Sep 22, 2017 | Buy | $2.23 | 10,000 | 22,300 | 303,000 | Sep 25, 2017, 04:34 PM |
| Taglietti Marco | Chief Executive Officer | Aug 23, 2017 | Buy | $1.85 | 4,993 | 9,237 | 292,000 | Aug 24, 2017, 09:28 AM |
| Taglietti Marco | Chief Executive Officer | Aug 22, 2017 | Buy | $1.61 | 7 | 11 | 287,007 | Aug 24, 2017, 09:28 AM |
| Taglietti Marco | Chief Executive Officer | Aug 15, 2017 | Buy | $1.61 | 10,000 | 16,100 | 287,000 | Aug 17, 2017, 09:32 AM |
| Angulo Gonzalez David | Chief Medical Officer | Aug 11, 2017 | Buy | $1.55 | 10,000 | 15,500 | 72,000 | Aug 14, 2017, 04:29 PM |
| HASTINGS DAVID C | Director | Jun 21, 2017 | Buy | $1.75 | 20,000 | 35,000 | 20,000 | Jun 22, 2017, 08:58 AM |
| Taglietti Marco | Chief Executive Officer | May 12, 2017 | Buy | $1.69 | 25,000 | 42,250 | 277,000 | May 15, 2017, 08:17 AM |
| Angulo Gonzalez David | Chief Medical Officer | May 12, 2017 | Buy | $1.70 | 15,000 | 25,500 | 62,000 | May 15, 2017, 08:17 AM |
| Taglietti Marco | Chief Executive Officer | Dec 21, 2016 | Buy | $3.30 | 25,000 | 82,500 | 251,000 | Dec 22, 2016, 06:05 AM |
| Angulo Gonzalez David | Chief Medical Officer | Dec 16, 2016 | Buy | $3.25 | 4,000 | 13,000 | 46,000 | Dec 19, 2016, 06:44 AM |
| Machado Patrick | Director | Sep 15, 2016 | Buy | $2.94 | 40,000 | 117,600 | 60,000 | Sep 16, 2016, 08:50 AM |
| Angulo Gonzalez David | Chief Medical Officer | Jun 29, 2016 | Buy | $2.18 | 4,800 | 10,464 | 8,850 | Jul 01, 2016, 10:31 AM |
| Angulo Gonzalez David | Chief Medical Officer | Jun 30, 2016 | Buy | $2.23 | 32,150 | 71,695 | 41,000 | Jul 01, 2016, 10:31 AM |
| Machado Clarence Patrick | Director | Jun 24, 2016 | Buy | $2.39 | 20,000 | 47,800 | 20,000 | Jun 28, 2016, 07:53 AM |
| Francois Eric | Chief Financial Officer | Jun 24, 2016 | Buy | $2.39 | 15,000 | 35,850 | 15,000 | Jun 28, 2016, 07:53 AM |
| Taglietti Marco | Chief Executive Officer | Jun 24, 2016 | Buy | $2.39 | 100,000 | 239,000 | 225,000 | Jun 28, 2016, 07:53 AM |
| Macdonald Guy | Director | Jun 24, 2016 | Buy | $2.39 | 40,000 | 95,600 | 40,000 | Jun 28, 2016, 07:52 AM |
| Taglietti Marco | Chief Executive Officer | May 25, 2016 | Buy | $3.20 | 246 | 787 | 125,000 | May 27, 2016, 03:54 PM |
| HANHAM ANN | Director | May 25, 2016 | Buy | $3.64 | 4,225 | 15,379 | 4,225 | May 27, 2016, 01:53 PM |
| Taglietti Marco | Chief Executive Officer | May 25, 2016 | Buy | $3.26 | 5,754 | 18,758 | 124,754 | May 27, 2016, 09:16 AM |
| Taglietti Marco | Chief Executive Officer | May 24, 2016 | Buy | $3.37 | 5,500 | 18,535 | 119,000 | May 25, 2016, 09:00 AM |
| Taglietti Marco | Chief Executive Officer | May 23, 2016 | Buy | $3.15 | 3,000 | 9,450 | 113,500 | May 24, 2016, 09:30 AM |
| Taglietti Marco | Chief Executive Officer | May 20, 2016 | Buy | $3.14 | 4,500 | 14,130 | 110,500 | May 24, 2016, 09:30 AM |
| Taglietti Marco | Chief Executive Officer | May 19, 2016 | Buy | $3.07 | 6,000 | 18,420 | 106,000 | May 20, 2016, 08:06 AM |
| Taglietti Marco | Chief Executive Officer | Nov 24, 2015 | Buy | $6.80 | 7,733 | 52,584 | 100,000 | Nov 24, 2015, 05:47 PM |
| Taglietti Marco | Chief Executive Officer | Nov 23, 2015 | Buy | $6.79 | 15,000 | 101,850 | 92,267 | Nov 24, 2015, 05:47 PM |
| Angulo Gonzalez David | Chief Medical Officer | Sep 15, 2015 | Buy | $7.00 | 3,000 | 21,000 | 3,000 | Sep 18, 2015, 04:59 PM |
| Taglietti Marco | Chief Executive Officer | Aug 31, 2015 | Buy | $7.82 | 25,000 | 195,500 | 77,267 | Sep 02, 2015, 09:51 PM |
| Taglietti Marco | Chief Executive Officer | Aug 28, 2015 | Buy | $7.15 | 400 | 2,860 | 52,267 | Aug 31, 2015, 06:52 PM |
| Taglietti Marco | Chief Executive Officer | Aug 27, 2015 | Buy | $7.07 | 1,867 | 13,200 | 51,867 | Aug 31, 2015, 06:52 PM |
| Taglietti Marco | Chief Executive Officer | Aug 26, 2015 | Buy | $6.98 | 25,000 | 174,500 | 50,000 | Aug 27, 2015, 04:56 PM |
| Taglietti Marco | Chief Executive Officer | Aug 25, 2015 | Buy | $7.15 | 25,000 | 178,800 | 25,000 | Aug 27, 2015, 04:56 PM |
| F.C.P.R. Genavent | 10% Owner | May 07, 2014 | Buy | $10.00 | 10,000 | 100,000 | 237,598 | May 09, 2014, 02:36 PM |
| F.C.P.R. Genavent | 10% Owner | May 07, 2014 | Option Exercise | $0.20 | 14,003 | 2,801 | 14,003 | May 09, 2014, 02:36 PM |
| Arthaud Laurent | Director | May 07, 2014 | Option Exercise | $0.20 | 290 | 58 | 4,028 | May 08, 2014, 09:43 PM |
| FCPR Biotechnology Fund | 10% Owner | May 07, 2014 | Buy | $10.00 | 50,000 | 500,000 | 295,077 | May 08, 2014, 09:32 PM |
| FCPR Biotechnology Fund | 10% Owner | May 07, 2014 | Option Exercise | $0.20 | 36,500 | 7,300 | 36,500 | May 08, 2014, 09:32 PM |
| Nothias Jean-Yves | Director | May 07, 2014 | Buy | $10.00 | 50,000 | 500,000 | 295,077 | May 08, 2014, 09:31 PM |
| Nothias Jean-Yves | Director | May 07, 2014 | Option Exercise | $0.20 | 36,500 | 7,300 | 36,500 | May 08, 2014, 09:31 PM |
| ALTA BIOPHARMA PARTNERS II LP | 10% Owner | May 07, 2014 | Buy | $10.00 | 31,934 | 319,340 | 45,736 | May 08, 2014, 09:29 PM |
| ALTA BIOPHARMA PARTNERS II LP | 10% Owner | May 07, 2014 | Buy | $10.00 | 868,066 | 8,680,660 | 1,240,575 | May 08, 2014, 09:29 PM |
| ALTA BIOPHARMA PARTNERS II LP | 10% Owner | May 07, 2014 | Option Exercise | $0.20 | 3,381 | 676 | 3,381 | May 08, 2014, 09:29 PM |
| ALTA BIOPHARMA PARTNERS II LP | 10% Owner | May 07, 2014 | Option Exercise | $0.20 | 91,556 | 18,311 | 91,556 | May 08, 2014, 09:29 PM |
| KIRBY PAMELA J | Director | May 07, 2014 | Option Exercise | $0.20 | 12,745 | 2,549 | 12,745 | May 08, 2014, 09:28 PM |
| Ventech Capital II | 10% Owner | May 07, 2014 | Buy | $10.00 | 28,000 | 280,000 | 414,211 | May 08, 2014, 09:25 PM |
| Ventech Capital II | 10% Owner | May 07, 2014 | Option Exercise | $0.20 | 71,714 | 14,343 | 71,714 | May 08, 2014, 09:25 PM |
| Ribeill Yves J | President and CEO | May 07, 2014 | Option Exercise | $0.20 | 595 | 119 | 595 | May 08, 2014, 09:24 PM |
| Langlois Patrick | Director | May 07, 2014 | Option Exercise | $0.20 | 5,251 | 1,050 | 26,785 | May 08, 2014, 09:23 PM |
Load More Insider Transactions
Buy
Sale
Option Exercise
| Owner | Relationship | Date | Value($) |
| Sukenick Scott | Chief Legal Officer | 02/16/2024 | 24,742 |
| Taglietti Marco | Chief Executive Officer | 04/26/2022 | 225,000 |
| Sukenick Scott | General Counsel | 04/26/2022 | 10,500 |
| PERCEPTIVE ADVISORS LLC | 10% Owner | 01/21/2021 | 701,100 |
| PERCEPTIVE ADVISORS LLC | 10% Owner | 01/20/2021 | 1,374,550 |
| PERCEPTIVE ADVISORS LLC | 10% Owner | 01/22/2021 | 2,629,781 |
| Tinmouth Brian Philippe | Director | 12/21/2020 | 50,000 |
| Taglietti Marco | Chief Executive Officer | 12/21/2020 | 250,000 |
| Sukenick Scott | General Counsel | 12/21/2020 | 10,000 |
| Macdonald Guy | Director | 12/21/2020 | 50,000 |
| HANHAM ANN | Director | 12/21/2020 | 20,000 |
| GILMAN STEVEN C | Director | 12/21/2020 | 25,000 |
| Francois Eric | Chief Financial Officer | 12/21/2020 | 3,750 |
| ANIDO ARMANDO | Director | 12/21/2020 | 31,250 |
| Angulo Gonzalez David | Chief Medical Officer | 12/21/2020 | 10,000 |
| Sukenick Scott | General Counsel | 11/25/2020 | 17,795 |
| Sukenick Scott | General Counsel | 02/15/2020 | 7,673 |
| Francois Eric | Chief Financial Officer | 11/25/2020 | 23,699 |
| Francois Eric | Chief Financial Officer | 02/15/2020 | 9,594 |
| Angulo Gonzalez David | Chief Medical Officer | 11/25/2020 | 29,440 |
| Angulo Gonzalez David | Chief Medical Officer | 02/15/2020 | 11,515 |
| Taglietti Marco | Chief Executive Officer | 12/12/2019 | 150,000 |
| Taglietti Marco | Chief Executive Officer | 08/21/2019 | 10,545 |
| Taglietti Marco | Chief Executive Officer | 08/20/2019 | 555 |
| Taglietti Marco | Chief Executive Officer | 08/15/2019 | 10,115 |
| Taglietti Marco | Chief Executive Officer | 04/17/2019 | 40,750 |
| Taglietti Marco | Chief Executive Officer | 01/10/2019 | 17,250 |
| Taglietti Marco | Chief Executive Officer | 12/31/2018 | 11,500 |
| Angulo Gonzalez David | Chief Medical Officer | 12/31/2018 | 5,951 |
| Angulo Gonzalez David | Chief Medical Officer | 09/06/2018 | 8,890 |
| Taglietti Marco | Chief Executive Officer | 08/23/2018 | 32,250 |
| Angulo Gonzalez David | Chief Medical Officer | 03/29/2018 | 8,160 |
| Angulo Gonzalez David | Chief Medical Officer | 03/08/2018 | 9,730 |
| HASTINGS DAVID C | Director | 03/08/2018 | 19,999 |
| Sukenick Scott | General Counsel | 03/08/2018 | 5,001 |
| Taglietti Marco | Chief Executive Officer | 03/08/2018 | 169,000 |
| Francois Eric | Chief Financial Officer | 03/08/2018 | 10,000 |
| Angulo Gonzalez David | Chief Medical Officer | 03/08/2018 | 24,995 |
| Taglietti Marco | Chief Executive Officer | 09/22/2017 | 22,300 |
| Taglietti Marco | Chief Executive Officer | 08/23/2017 | 9,237 |
| Taglietti Marco | Chief Executive Officer | 08/22/2017 | 11 |
| Taglietti Marco | Chief Executive Officer | 08/15/2017 | 16,100 |
| Angulo Gonzalez David | Chief Medical Officer | 08/11/2017 | 15,500 |
| HASTINGS DAVID C | Director | 06/21/2017 | 35,000 |
| Taglietti Marco | Chief Executive Officer | 05/12/2017 | 42,250 |
| Angulo Gonzalez David | Chief Medical Officer | 05/12/2017 | 25,500 |
| Taglietti Marco | Chief Executive Officer | 12/21/2016 | 82,500 |
| Angulo Gonzalez David | Chief Medical Officer | 12/16/2016 | 13,000 |
| Machado Patrick | Director | 09/15/2016 | 117,600 |
| Angulo Gonzalez David | Chief Medical Officer | 06/29/2016 | 10,464 |
| Angulo Gonzalez David | Chief Medical Officer | 06/30/2016 | 71,695 |
| Machado Clarence Patrick | Director | 06/24/2016 | 47,800 |
| Francois Eric | Chief Financial Officer | 06/24/2016 | 35,850 |
| Taglietti Marco | Chief Executive Officer | 06/24/2016 | 239,000 |
| Macdonald Guy | Director | 06/24/2016 | 95,600 |
| Taglietti Marco | Chief Executive Officer | 05/25/2016 | 787 |
| HANHAM ANN | Director | 05/25/2016 | 15,379 |
| Taglietti Marco | Chief Executive Officer | 05/25/2016 | 18,758 |
| Taglietti Marco | Chief Executive Officer | 05/24/2016 | 18,535 |
| Taglietti Marco | Chief Executive Officer | 05/23/2016 | 9,450 |
| Taglietti Marco | Chief Executive Officer | 05/20/2016 | 14,130 |
| Taglietti Marco | Chief Executive Officer | 05/19/2016 | 18,420 |
| Taglietti Marco | Chief Executive Officer | 11/24/2015 | 52,584 |
| Taglietti Marco | Chief Executive Officer | 11/23/2015 | 101,850 |
| Angulo Gonzalez David | Chief Medical Officer | 09/15/2015 | 21,000 |
| Taglietti Marco | Chief Executive Officer | 08/31/2015 | 195,500 |
| Taglietti Marco | Chief Executive Officer | 08/28/2015 | 2,860 |
| Taglietti Marco | Chief Executive Officer | 08/27/2015 | 13,200 |
| Taglietti Marco | Chief Executive Officer | 08/26/2015 | 174,500 |
| Taglietti Marco | Chief Executive Officer | 08/25/2015 | 178,800 |
| F.C.P.R. Genavent | 10% Owner | 05/07/2014 | 100,000 |
| F.C.P.R. Genavent | 10% Owner | 05/07/2014 | 2,801 |
| Arthaud Laurent | Director | 05/07/2014 | 58 |
| FCPR Biotechnology Fund | 10% Owner | 05/07/2014 | 500,000 |
| FCPR Biotechnology Fund | 10% Owner | 05/07/2014 | 7,300 |
| Nothias Jean-Yves | Director | 05/07/2014 | 500,000 |
| Nothias Jean-Yves | Director | 05/07/2014 | 7,300 |
| ALTA BIOPHARMA PARTNERS II LP | 10% Owner | 05/07/2014 | 319,340 |
| ALTA BIOPHARMA PARTNERS II LP | 10% Owner | 05/07/2014 | 8,680,660 |
| ALTA BIOPHARMA PARTNERS II LP | 10% Owner | 05/07/2014 | 676 |
| ALTA BIOPHARMA PARTNERS II LP | 10% Owner | 05/07/2014 | 18,311 |
| KIRBY PAMELA J | Director | 05/07/2014 | 2,549 |
| Ventech Capital II | 10% Owner | 05/07/2014 | 280,000 |
| Ventech Capital II | 10% Owner | 05/07/2014 | 14,343 |
| Ribeill Yves J | President and CEO | 05/07/2014 | 119 |
| Langlois Patrick | Director | 05/07/2014 | 1,050 |
Load More Insider Transactions
FUNDS WITH A POSITION IN SCYNEXIS INC
| Fund | # Shares Owned | % of Portfolio | % Change | Investing Style |
|---|---|---|---|---|
| BLACKROCK INC. | 434,078 | 0.00002% | 0.74% | Other |
| GEODE CAPITAL MANAGEMENT, LLC | 355,913 | 0.00008% | 5.01% | Other |
| RENAISSANCE TECHNOLOGIES LLC | 230,940 | 0.0008% | 325.77% | Other |
| UBS OCONNOR LLC | 189,467 | 0.03% | -48.24% | Value |
CHANGE IN SHARES OUTSTANDING FOR SCYNEXIS INC
STOCK BUYBACKS FOR SCYNEXIS INC
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
Load More
Period of Report: 12/31/2023
10-K/10-Q Filings: View
Previous Period
% Change in Shares
Quarter
09/30/2023
0.06%
1Q
06/30/2023
0.18%
2Q
03/31/2023
0.35%
3Q
12/31/2022
0.77%
4Q
09/30/2022
0.88%
5Q
06/30/2022
10.71%
6Q
03/31/2022
49.52%
7Q
12/31/2021
76.86%
8Q
09/30/2021
80.05%
9Q
06/30/2021
84.21%
10Q
03/31/2021
85.73%
11Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR SCYNEXIS INC
LOADING...